Covered recipient · General Payments record
JOCHEN H LORCH
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$32,560.00
- Reported across 43 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $7,533.75 | 2 |
| Honoraria | $2,025.00 | 1 |
| Travel and Lodging | $1,647.23 | 3 |
| Food and Beverage | $231.91 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $7,102.12 | 5 |
| Coherus Biosciences Inc. | $2,177.02 | 2 |
| EISAI INC. | $2,158.75 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Coherus Biosciences Inc. | $152.02 | 06/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147278300 | CMS |
| Coherus Biosciences Inc. | $2,025.00 | 06/02/2024 | Honoraria | Undisputed | 01/23/2026 | 1147278302 | CMS |
| Eisai Inc. | $2,158.75 | 02/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110752968 | CMS |
| Novartis Pharmaceuticals Corporation | $354.68 | 02/20/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1087106252 | CMS |
| Novartis Pharmaceuticals Corporation | $5,375.00 | 02/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1087106254 | CMS |
| Novartis Pharmaceuticals Corporation | $79.89 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087106256 | CMS |
| Novartis Pharmaceuticals Corporation | $201.38 | 02/21/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1087106258 | CMS |
| Novartis Pharmaceuticals Corporation | $1,091.17 | 02/21/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1087106260 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.